Literature DB >> 17963919

Pitfalls in treatment of acute cervical spinal cord injury using high-dose methylprednisolone: a retrospect audit of 111 patients.

Han-Chung Lee1, Der-Yang Cho, Wen-Yuan Lee, Hao-Che Chuang.   

Abstract

BACKGROUND: Earlier studies suggested that the use of high-dose IV MP was the gold standard of care for the treatment of ASCI, but this has been debated. This study aims to identify the effects of high-dose MP in treatment of cervical SCI and how the treatment might be improved.
METHODS: The medical records of 138 patients with cervical spinal injury secondary to blunt injuries were retrospectively reviewed to determine the steroid administration protocol, effects, and complications. The findings on admission were compared with those at discharge and at the most recent outpatient follow-up visit. Significant neurologic improvement was defined as increase in at least 1 clinical grade according to the Frankel classification system.
RESULTS: Significantly more motor and sensory recovery was noted (complete ASCI, 69% vs 0; incomplete ASCI, 70% vs 50%) in patients treated with surgery and MP than in patients without such treatment. Moreover, 87% (14/16) of patients with complete ASCI (unlike patients with incomplete [8/28, 28.6%] and mild [2/14, 14.3%] ASCI) treated with MP had steroid-related complications, and 1 patient died from sepsis related to a perforated peptic ulcer. Mean hospitalization was significantly shorter for the patients who underwent tracheostomy (49 days, ranged from 22 to 110 days) vs nontracheostomy(94 days, ranged from 28-268 days).
CONCLUSION: Early intervention with surgery and MP is critical. Although treatment with MP for 24 or 48 hours significantly improves motor and sensory function of patients with ASCI, harmful side effects limit its functional efficacy in patients with complete ASCI. Early tracheostomy can shorten hospital stay in patients with complete ASCI.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17963919     DOI: 10.1016/j.surneu.2007.06.085

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  7 in total

1.  Neural Stem Cell-Conditioned Medium Suppresses Inflammation and Promotes Spinal Cord Injury Recovery.

Authors:  Zhijian Cheng; Dale B Bosco; Li Sun; Xiaoming Chen; Yunsheng Xu; Wenjiao Tai; Ruth Didier; Jinhua Li; Jianqing Fan; Xijing He; Yi Ren
Journal:  Cell Transplant       Date:  2016-10-12       Impact factor: 4.064

Review 2.  Remote neurodegeneration: multiple actors for one play.

Authors:  Maria Teresa Viscomi; Marco Molinari
Journal:  Mol Neurobiol       Date:  2014-01-19       Impact factor: 5.590

3.  Clinical and experimental advances in regeneration of spinal cord injury.

Authors:  Jung Keun Hyun; Hae-Won Kim
Journal:  J Tissue Eng       Date:  2010-11-02       Impact factor: 7.813

4.  Effect of endogenous androgens on 17beta-estradiol-mediated protection after spinal cord injury in male rats.

Authors:  Supatra Kachadroka; Alicia M Hall; Tracy L Niedzielko; Sukumal Chongthammakun; Candace L Floyd
Journal:  J Neurotrauma       Date:  2010-03       Impact factor: 5.269

Review 5.  The role of pharmacotherapy in modifying the neurological status of patients with spinal and spinal cord injuries.

Authors:  Renato Carlos do Vale Ramos; Nuno Alegrete
Journal:  Rev Bras Ortop       Date:  2015-10-01

6.  Single-Session Combined Anterior-Posterior Approach for Treatment of Ankylosing Spondylitis with Obvious Displaced Lower Cervical Spine Fractures and Dislocations.

Authors:  Baohui Yang; Teng Lu; Haopeng Li
Journal:  Biomed Res Int       Date:  2017-01-04       Impact factor: 3.411

Review 7.  Review: Steroid Use in Patients With Acute Spinal Cord Injury and Guideline Update.

Authors:  Byung-Jou Lee; Je Hoon Jeong
Journal:  Korean J Neurotrauma       Date:  2022-04-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.